BIOVAXYS ANNOUNCES UPSIZING OF PRIVATE PLACEMENT
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce an increase to its ...
EQS-News: BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
EQS-News: BRAIN Biotech AG / Key word (s): Contract BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator 20.09.2024 / 19:50 CET/CEST ...
News Medical2d
analytica expands its international network to the USA
USA in Columbus, Ohio, in fall 2025, to cover the North American market. The new offshoot of the world's leading trade fair ...
MSNBC4d
JD Vance does a terrible Donald Trump impression
Claiming that he’d gotten the footage ahead of time, Vance shared a clip from the 2007 Miss Teen USA contest, where a contestant went viral for her disjointed answer. When Vance appeared on CNN ...
Lipid Nanoparticles Market to Reach USD 350.5M by 2029 | MarketsandMarkets™
The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a ...
It was 'tough on China' week in Congress, one of the few issues both parties agree on
Lawmakers took up more than two dozen mostly Republican-led measures aimed at countering Beijing’s technological, political ...
Business Insider6d
PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
16, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and ...